The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 26, 2023
Filed:
May. 10, 2021
Applicant:
Takeda Pharmaceutical Company Limited, Osaka, JP;
Inventors:
Satoshi Yamamoto, Fujisawa, JP;
Junya Shirai, Fujisawa, JP;
Mitsunori Kono, Fujisawa, JP;
Yoshihide Tomata, San Diego, CA (US);
Ayumu Sato, Fujisawa, JP;
Atsuko Ochida, Fujisawa, JP;
Yoshiyuki Fukase, New York, NY (US);
Shoji Fukumoto, Kobe, JP;
Tsuneo Oda, Fujisawa, JP;
Hidekazu Tokuhara, Fujisawa, JP;
Naoki Ishii, Fujisawa, JP;
Yusuke Sasaki, Fujisawa, JP;
Assignee:
TAKEDA PHARMACEUTICAL COMPANY LIMITED, Osaka, JP;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07F 7/08 (2006.01); C07D 205/04 (2006.01); C07D 207/12 (2006.01); C07K 5/065 (2006.01); C07D 239/36 (2006.01); C07D 213/64 (2006.01); C07D 309/06 (2006.01); C07D 333/38 (2006.01); C07F 7/10 (2006.01); C07D 403/06 (2006.01); C07D 271/10 (2006.01); C07C 237/22 (2006.01); C07D 295/14 (2006.01); C07D 207/26 (2006.01); C07D 413/12 (2006.01); C07F 7/30 (2006.01); C07D 233/72 (2006.01); C07D 309/08 (2006.01); C07D 231/56 (2006.01); C07D 261/08 (2006.01); C07D 209/18 (2006.01); C07D 405/12 (2006.01); C07D 261/12 (2006.01); C07D 239/54 (2006.01); C07D 211/62 (2006.01); C07D 237/14 (2006.01); C07D 231/12 (2006.01); C07D 487/04 (2006.01); A61P 43/00 (2006.01); A61P 29/00 (2006.01); A61P 25/00 (2006.01); A61P 19/02 (2006.01); A61P 17/06 (2006.01); A61P 1/04 (2006.01); C07K 5/087 (2006.01);
U.S. Cl.
CPC ...
C07F 7/0812 (2013.01); A61P 1/04 (2018.01); A61P 17/06 (2018.01); A61P 19/02 (2018.01); A61P 25/00 (2018.01); A61P 29/00 (2018.01); A61P 43/00 (2018.01); C07C 237/22 (2013.01); C07D 205/04 (2013.01); C07D 207/12 (2013.01); C07D 207/26 (2013.01); C07D 209/18 (2013.01); C07D 211/62 (2013.01); C07D 213/64 (2013.01); C07D 231/12 (2013.01); C07D 231/56 (2013.01); C07D 233/72 (2013.01); C07D 237/14 (2013.01); C07D 239/36 (2013.01); C07D 239/54 (2013.01); C07D 261/08 (2013.01); C07D 261/12 (2013.01); C07D 271/10 (2013.01); C07D 295/14 (2013.01); C07D 309/06 (2013.01); C07D 309/08 (2013.01); C07D 333/38 (2013.01); C07D 403/06 (2013.01); C07D 405/12 (2013.01); C07D 413/12 (2013.01); C07D 487/04 (2013.01); C07F 7/081 (2013.01); C07F 7/10 (2013.01); C07F 7/30 (2013.01); C07K 5/06078 (2013.01); C07K 5/0812 (2013.01);
Abstract
The present invention relates to compound (I) or a salt thereof which has a RORγt inhibitory action. In the formula (I), each symbol is as defined in the specification.